Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm
The Economic Times has reported a new India-focused foreign affairs development: “Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm.” The publisher's feed describes the story as follows: Trump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufacturing and supply chain strategies. After this period, tariffs will escalate significantly, impacting export economics. Several Indi
Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.


